Biotie: Change in the number of votes

| Source: Biotie Therapies
BIOTIE THERAPIES CORP.       Stock Exchange Release            28 February 2014
AT 8.50 AM

Biotie: Change in the number of votes

Biotie Therapies Corp. ("Biotie" or the "Company") has conveyed Biotie shares
held as treasury shares and that were issued on 2 January 2014 pursuant to the
Stock Option Plan 2011 and the Equity Incentive Plan 2011 as follows:

Shares conveyed   Cumulative shares conveyed        Remaining shares to be
                     since 2 January 2014                  conveyed

     15,000                 338,750                       2,982,910

Under the Stock Option Plan 2011, the owners of the stock options may subscribe
for a maximum total of 7,401,000 new shares in the Company or existing shares
held by the Company. No shares have been subscribed for during the period 28
January 2014 and 27 February 2014.

The first vesting period of the Equity Incentive Plan 2011 ended on 5 January
2014, after which the Company's shares shall be delivered to employees on the
basis of the granted share units. It was resolved pursuant to the authorization
of the Annual General Meeting of the Shareholders held on 4 April 2013 to issue
15,000 existing treasury shares to the employees without consideration for the
purposes of remunerating the employees pursuant to the terms and conditions of
the Equity Incentive Plan 2011 and thus, there is an especially weighty
financial reason to derogate from the pre-emptive right of the shareholders, as
referred to in Chapter 9 Section 4(1) of the Companies Act (624/2006, as

The conveyed shares previously held as treasury shares have not carried any
voting rights. The conveyance does not affect the number of registered shares.
After the conveyances the changes are as follows:

   Increase in number of     Total amount of     Number of the     Total number
     outstanding shares       voting rights  Company's shares held of registered
                                                 by the Group         shares

           15,000              446,552,698         9,479,700        456,032,398

Turku, 28 February 2014

Biotie Therapies Corp.
Timo Veromaa, President and CEO

For further information, please contact:
Virve Nurmi, Investor Relations Manager, Biotie Therapies Corp.
tel. +358 2 274 8900, e-mail:

NASDAQ OMX Helsinki Ltd
Main Media